en

CONTROL study results show improved tolerability of NERLYNX® (neratinib) with all the investigated diarrhoea prophylaxis strategies

Today, the final findings of the CONTROL study1 were presented at the 2021 San Antonio Breast Cancer Symposium (SABCS). Results suggest that providing a prophylactic anti-diarrhoea medical treatment or applying a dose escalation schedule of neratinib associated with loperamide (as necessary) at treatment initiation over two-weeks reduces the incidence, severity, and duration of neratinib-associated grade 3 […]

thaipr.net

13 ธ.ค. 64

Ataccama Partners with UST to Transform Enterprise Data Governance

Ataccama is excited to bring on UST as a strategic Value-Added Reseller in North America Ataccama, a leading Enterprise Data Quality Fabric provider, and UST, a leading digital transformation solutions company, have announced a partnership to deliver AI-powered data management solutions to enterprise organizations. The Ataccama ONE Data Quality Fabric delivers high quality data to relevant teams and […]

thaipr.net

13 ธ.ค. 64

Research shows Lianhua Qingwen capsules conferred preventive effects on those exposed to COVID-19

“Lianhua Qingwen capsules conferred preventive effects on those exposed to COVID-19”, claimed an article titled “Efficacy and Safety of Lianhuaqingwen Capsules for the Prevention of Coronavirus Disease 2019: A Prospective Open-Label Controlled Trial”, published November in the journal of Evidence-based Complementary and Alternative Medicine. According to the article, this is the first clinical trial that demonstrates…

thaipr.net

13 ธ.ค. 64

OneConnect Recognized in World’s Top Ten Fintech Companies in 2021 in Patent Quality List

OneConnect Financial Technology Co., Ltd. (NYSE: OCFT) (“OneConnect”), a key driver of fintech strategy for associate Ping An Insurance Group of China (“Ping An”), has helped the group to top the list of the World’s Top Ten Fintech Companies in 2021 in Patent Quality, followed by Ant Group and Alibaba. The list recently announced by 01Caijing Research […]

thaipr.net

13 ธ.ค. 64

Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021

– Trial met both primary endpoints demonstrating statistically significant and clinically meaningful extension of progression free survival (PFS) as monotherapy vs. standard of care (SoC) endocrine therapy in overall population and estrogen receptor mutation (mESR1) population – In the overall population, elacestrant reduced risk of progression or death by 30% vs. SoC – In the mESR1 population, […]

thaipr.net

13 ธ.ค. 64
1 … 2,613 2,614 2,615 2,616 2,617 … 3,358

Copyright © 2026 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.